Page 101 | Certara

On-Demand Webinar

Therapeutic Proteins’ Drug-Drug Interactions: Updates & Challenges

Therapeutic proteins (TP) - and more specifically monoclonal antibodies - are part of the therapeutic…

CertaraDecember 5, 2022

Brochure

BaseCase Portal

CertaraNovember 30, 2022

Press Coverage

Project Optimus: How to Prepare for Success

For some time now, cancer drug developers have known “Project Optimus” and new dose optimization…

CertaraNovember 28, 2022

White Paper

The eCTD Submission Process: Tips and Tricks for Drug Development Success

Our experts compiled the tips and best practices you need to know for a successful…

CertaraNovember 22, 2022

Blog

Tips & Tricks for Data Management in Phoenix WinNonlin

Learn some tips & tricks for the Data Wizard, a data management tool in Phoenix,…

CertaraNovember 18, 2022

Blog

Tips to Use Phoenix WinNonlin More Efficiently

Certara’s Phoenix™ Pharmacokinetic and Pharmacodynamic (PK/PD) Platform is the single, interoperable hub for sharing pre-clinical…

CertaraNovember 7, 2022

Press Release

Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase

Arsenal will acquire approximately 30M shares at $15 per share from funds controlled by EQT…

CertaraNovember 7, 2022

Blog

The Role of PBPK Modeling & Simulation in Infants & Neonates

Many factors make it challenging to obtain adequate pediatric samples for use in drug development…

CertaraNovember 4, 2022

Case Study

Using PBPK Models to Predict Effects of Hepatic Impairment & DDI in Olanzapine/Samidorphan Combination Therapy

Olanzapine is an effective antipsychotic medication used to treat schizophrenia, a disease that affects about…

CertaraOctober 31, 2022

Blog

Why you should select your drug formulation before starting clinical studies

Drug developers often rush through the discovery process to get into human testing. Most are…

CertaraOctober 28, 2022

Therapeutic Proteins’ Drug-Drug Interactions: Updates & Challenges

BaseCase Portal

Project Optimus: How to Prepare for Success

The eCTD Submission Process: Tips and Tricks for Drug Development Success

Tips & Tricks for Data Management in Phoenix WinNonlin

Tips to Use Phoenix WinNonlin More Efficiently

Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase

The Role of PBPK Modeling & Simulation in Infants & Neonates

Using PBPK Models to Predict Effects of Hepatic Impairment & DDI in Olanzapine/Samidorphan Combination Therapy

Why you should select your drug formulation before starting clinical studies

Newsletter sign up

Quick links

Solutions

Contact